Mubadala Capital

Activity from announced rounds

Activity in this selectionJul 31, 2024 · Jul 1, 2024

Mubadala Capital is the investment manager whose official portfolio includes Ollin, Alloy, Juvena and Crusoe.

Recorded funding activity

Ollin develops retinal-disease antibodies. Alloy supplies discovery platforms and services, while Crusoe develops computing infrastructure. The manager remains separate from Mubadala Investment Company; the Precision Neuroscience relation stays in draft.

Sources
Rounds participated in
0
Confirmed lead rounds
—
All roles disclosed
New companies
0
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

No activity in this selection.

By primary sector

No activity in this selection.

By country

No activity in this selection.

Rounds

0 in this selection

No rounds match this selection.